Rihua Xie

Dr. Rihua Xie


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2023 in Cell Host & Microbe
Verified
Journal Article
Closed access
LZLepeng Zhou
Lepeng Zhou
WQWen Qiu
Wen Qiu
JWJie Wang
Jie Wang
AZAihua Zhao
Aihua Zhao
CZChuhui Zhou
Chuhui Zhou
YHYan He
Yan He

7 October 2021 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
LZLiuhong Zhao
Liuhong Zhao
JCJingfen Chen
Jingfen Chen
LLLiuying Lan
Liuying Lan
NDNi Deng
Ni Deng
YLYan Liao
Yan Liao
RXRuihua Xie
Ruihua Xie
Background: Postpartum depression (PPD) is a prevalent mental health problem with serious adverse consequences for affected women and their infants. Clinical trials have found that telehealth interventions for women with PPD result in increased accessibility and improved treatment effectiveness. However, no comprehensive synthesis of evidence from clinical trials by systematic review has been conducted. Objective: The aim of this study is to evaluate the effectiveness of telehealth interventions in reducing depressive symptoms and anxiety in women with PPD. To enhance the homogeneity and interpretability of the findings, this systematic review focuses on PPD measured by the Edinburgh Postnatal Depression Scale (EPDS). Methods: PubMed, The Cochrane Library, CINAHL, PsycINFO, CNKI, and Wanfang were electronically searched to identify randomized controlled trials (RCTs) on the effectiveness of telehealth interventions for women with PPD from inception to February 28, 2021. Data extraction and quality assessment were performed independently by two researchers. The quality of included studies was assessed using the Cochrane risk-of-bias tool, and meta-analysis was performed using RevMan 5.4 software. Results: Following the search, 9 RCTs with a total of 1958 women with PPD were included. The EPDS (mean difference=–2.99, 95% CI –4.52 to –1.46; P<.001) and anxiety (standardized mean difference=–0.39, 95% CI –0.67 to –0.12; P=.005) scores were significantly lower in the telehealth group compared with the control group. Significant subgroup differences were found in depressive symptoms according to the severity of PPD, telehealth technology, specific therapy, and follow-up time (P<.001). Conclusions: Telehealth interventions could effectively reduce the symptoms of depression and anxiety in women with PPD. However, better designed and more rigorous large-scale RCTs targeting specific therapies are needed to further explore the potential of telehealth interventions for PPD. Trial Registration: PROSPERO CRD42021258541; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=258541

1 August 2007 in Social Science & Medicine
Verified
Journal Article
Closed access
RXRuihua Xie
Ruihua Xie
GHGuoping He
Guoping He
ALAizhong Liu
Aizhong Liu
JBJacques Bradwejn
Jacques Bradwejn
MWMark Walker
Mark Walker
SWShi Wu Wen
Shi Wu Wen

1 March 2021 in The Journal of Alternative and Complementary Medicine
Verified
Journal Article
Closed access
LZLe-Peng Zhou
Le-Peng Zhou
JWJie Wang
Jie Wang
RXRuihua Xie
Ruihua Xie
SPSmita Pakhale
Smita Pakhale
DKDaniel Krewski
Daniel Krewski
SWShi Wu Wen
Shi Wu Wen
Background: Coronavirus disease 2019 (COVID-19) has become a pandemic with no specific and widely accepted effective drug or vaccine. However, studies have shown that Traditional Chinese Medicine (TCM) may play a significant role as an auxiliary treatment for COVID-19. Objective: This study aimed to assess the effects of TCM as an auxiliary treatment for COVID-19 through a systematic review of randomized-controlled trials (RCTs). Methods: Four English and three Chinese language databases were searched from December 1, 2019, to June 30, 2020. RCTs comparing TCM in combination with Western medicine (WM) with the same WM therapies alone for confirmed COVID-19 patients were included. The outcome measures were cure rate, lowering of body temperature, cough relief, improvement in chest computed tomography (CT) images, deterioration of condition, and adverse effects. Methodological quality was assessed using the Cochrane risk-of-bias tool. A series of meta-analyses were conducted for selected outcomes using RevMan 5.3 software. The quality of evidence was appraised using the grading of recommendation, assessment, development, and evaluation (GRADE) recommendations. Results: Ten RCTs with a total of 1,285 patients were included. Compared with WM alone in treating COVID-19, WM with auxiliary treatment by TCM appears to have increased the cure rate (risk ratio [RR] 1.15 [95% confidence interval (CI) 1.04–1.26]), relieved cough (RR 1.32 [95% CI 1.15–1.52]), improved chest CT images (RR 1.23 [95% CI 1.11–1.37]), and reduced the number of cases transitioning from a moderate to severe condition (RR 0.58 [95% CI 0.43–0.77]). The authors are uncertain whether TCM combined WM has effects on fever normalization (RR 1.10 [95% CI 0.94–1.29]) or adverse effects (RR 0.81 (95% CI 0.42–1.57]). Although they evaluated the certainty of evidence for lowering body temperature and adverse effects as very low, and low for cure rate, certainty was evaluated as moderate for improvement in chest CT images, cough relief, and deterioration of condition. Conclusion: TCM may be an effective auxiliary treatment for COVID-19 patients, which is likely to help improve the main symptoms and reduce disease progression. However, due to the limited number of studies and apparent heterogeneity among them, a more definitive conclusion on the effect of TCM on lowering body temperature and adverse effects cannot be drawn at this time.

19 January 2023 in International Journal of Gynecology & Obstetrics
Verified
Journal Article
Closed access
XLXiaolu Lai
Xiaolu Lai
JCJingfen Chen
Jingfen Chen
HLHaiqi Li
Haiqi Li
LZLepeng Zhou
Lepeng Zhou
QHQianyi Huang
Qianyi Huang
RXRuihua Xie
Ruihua Xie

19 August 2021 in International Journal of Gynecology & Obstetrics
Verified
Journal Article
Closed access
YCYanfang Chen
Yanfang Chen
FIFaeeha Ismail
Faeeha Ismail
ZXZiyu Xiong
Ziyu Xiong
MLMeng Li
Meng Li
ICInnie Chen
Innie Chen
RXRuihua Xie
Ruihua Xie